Why the study?
Although adverse pregnancy outcomes in women with pulmonary hypertension have improved, maternal mortality remains high, prompting a description of maternal-fetal outcomes in this population.
Pregnancy in women with pulmonary hypertension remains associated with high maternal and fetal morbidity and mortality, particularly in those with idiopathic PAH, reinforcing guideline recommendations to avoid pregnancy.
Answers are grounded in this paper and cite their sources.
High maternal/fetal risks in PH pregnancies support avoiding pregnancy in iPAH; leaves open need for prospective data to refine counseling.
Background: In recent years, with the development of monitoring conditions and the promotion and application of pulmonary vascular targeted drugs, the adverse pregnancy outcomes in women with pulmonary hypertension (PH) have been improved, but the rate of maternal mortality is still high. The purpose of this study was to describe the Maternal-fetal outcomes in pulmonary artery hypertensive pregnant women. Methods: The clinical data of 154 pregnant women with PH, who were admitted to the Third Affiliated Hospital of Guangzhou Medical University from January 2011 to December 2020 were collected and analyzed comprehensively. Results: Among patients diagnosed as PH with transcardiac color Doppler ultrasonography, 6 (3.9%) had idiopathic pulmonary hypertension (iPAH), 41 patients (26.6%) of pulmonary arterial hypertension associated with congenital heart disease (CHD-PAH) , 45 patients (45.2%) of pulmonary arterial hypertension (oPAH) related to other diseases, and 62 patients (40.3%) of pulmonary arterial hypertension (LHD-PH) related to left heart disease. Systolic pulmonary artery pressure (sPAP) was 36-49mmHg in 53.2% of patients, 50-69mmHg in 22.1% and ≥70mmHg in 24.7%. Five (3.2%) pregnant women died within 1 week after delivery; iPAH had the highest mortality rate (3/6, 50%); the incidence of heart failure during pregnancy was 14.9%, the incidence of postpartum hemorrhage was 10.4%, and cesarean section accounted for 70.1%, iatrogenic abortion 14.3%, premature infants 42.9%, low birth weight infants 44.8%, birth asphyxia infants 14.9%, fetal mortality 5.2%, neonatal mortality 1.9%. The average birth weight of perinatal infants was 2334.9±814.6g. Conclusion: There are significant differences in adverse pregnancy outcomes among pregnant women with pulmonary hypertension caused by different etiologies (iPAH, CHD-PAH, oPAH and LHD-PH). In general, iPAH got the worst prognosis, LHD-PH got the second, and then oPAH. CHD-PAH has the best prognosis relatively. Therefore, PH patients will be advised to avoid pregnancy; standardized, whole-process, and multidisciplinary assisted maternal management is the key to improving the maternal and fetal outcomes of such high-risk pregnancies.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: